
Sign up to save your podcasts
Or


Why did news from a weight-loss drug pill trial boost Eli Lilly? And how are costs in the Medicare business affecting UnitedHealth? Plus, what ambitious goals has Netflix set for itself? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4
16651,665 ratings
Why did news from a weight-loss drug pill trial boost Eli Lilly? And how are costs in the Medicare business affecting UnitedHealth? Plus, what ambitious goals has Netflix set for itself? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,840 Listeners

3,223 Listeners

522 Listeners

4,362 Listeners

439 Listeners

1,646 Listeners

674 Listeners

1,450 Listeners

1,039 Listeners

1,304 Listeners

6,069 Listeners

1,556 Listeners

208 Listeners

1,322 Listeners

605 Listeners

151 Listeners

75 Listeners

145 Listeners